A functional human IgM response to HIV-1 Env after immunization with NYVAC HIV C
- 19 February 2007
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 21 (4) , 524-527
- https://doi.org/10.1097/qad.0b013e32803277f9
Abstract
Env-specific IgG and IgM were detected in 25 and 60%, respectively, of volunteers immunized with NYVAC expressing clade C gp120. The serum sample with the highest IgM titre but undetectable IgG neutralized the homologous isolate with a reciprocal IC90 titre of 7.8 in the absence of complement, and 24.4 in the presence of complement (P = 0.0003). These results suggest that vaccine-induced, Env-specific IgM may have antiviral activity and should be subjected to further investigation.Keywords
This publication has 8 references indexed in Scilit:
- Nonneutralizing Antibodies Are Able To Inhibit Human Immunodeficiency Virus Type 1 Replication in Macrophages and Immature Dendritic CellsJournal of Virology, 2006
- Human immunodeficiency virus 1 (HIV-1) envelope-dependent cell–cell fusion modulation by HIV-positive sera is related to disease progressionJournal of General Virology, 2005
- Detection of Antibody-Dependent Complement-Mediated Inactivation of both Autologous and Heterologous Virus in Primary Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2005
- Women with Cervicovaginal Antibody‐Dependent Cell‐Mediated Cytotoxicity Have Lower Genital HIV‐1 RNA LoadsThe Journal of Infectious Diseases, 2004
- Characterization of Molecular Features, Antigen-Binding, andin VitroProperties of IgG and IgM Variants of 4E10, an Anti-HIV Type 1 Neutralizing Monoclonal AntibodyAIDS Research and Human Retroviruses, 2004
- Characterization of Human Class-Switched Polymeric (Immunoglobulin M [IgM] and IgA) Anti-Human Immunodeficiency Virus Type 1 Antibodies 2F5 and 2G12Journal of Virology, 2003
- Characterization of a Virtually Full-Length Human Immunodeficiency Virus Type 1 Genome of a Prevalent Intersubtype (C/B′) Recombinant Strain in ChinaJournal of Virology, 2000
- Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo.The Journal of Immunology, 1996